Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Dehydrocorydaline (nitrate)

Dehydrocorydaline nitrate (13-Methylpalmatine nitrate) is an alkaloid. Dehydrocorydaline regulates protein expression of Bax, Bcl-2; activates caspase-7, caspase-8, and inactivates PARP[1]. Dehydrocorydaline nitrate elevates p38 MAPK activation. Anti-inflammatory and anti-cancer activities.[2]. Dehydrocorydaline nitrate shows strong anti-malarial effects (IC50 =38 nM), and low cytotoxicity (cell viability > 90%) using P. falciparum 3D7 strain[3].

Product Specifications

CAS Number

13005-09-9

Product Name Alternative

13-Methylpalmatine (nitrate)

UNSPSC

12352005

Target

Autophagy; Bcl-2 Family; Caspase; p38 MAPK; Parasite; PARP

Type

Natural Products

Related Pathways

Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; MAPK/ERK Pathway

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Infection

Assay Protocol

https://www.medchemexpress.com/dehydrocorydaline-nitrate.html

Purity

99.90

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

[O-][N+]([O-])=O.CC1=C(C=CC(OC)=C2OC)C2=C[N+]3=C1C4=CC(OC)=C(OC)C=C4CC3

Molecular Formula

C22H24N2O7

Molecular Weight

428.44

References & Citations

[1]Nonaka M, et al. Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts. Malar J. 2018 Jun 25;17 (1) :244. doi: 10.1186/s12936-018-2392-4.|[2]Xu Z, et al. Dehydrocorydaline inhibits breast cancer cells proliferation by inducing apoptosis in MCF-7 cells. Am J Chin Med. 2012;40 (1) :177-85.|[3]Yoo M, et al. Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation. Mol Med Rep. 2016 Oct;14 (4) :3029-36.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture and light)

Scientific Category

Natural Products

Clinical Information

No Development Reported

Isoform

Plasmodium

Citation 01

Research Square Preprint. 2020 Dec.|Aging (Albany NY) . 2021 May 11;13 (9) :12780-12799.|Aging (Albany NY) . 2021 Oct 7;13 (19) :23133-23148.|Andrology. 2025 Jun 16.|Arthritis Res Ther. 2025 May 31;27 (1) :118.|Biochem Biophys Res Commun. 2018 May 23;499 (4) :743-750. |Biochem Biophys Res Commun. 2018 Sep 5;503 (2) :467-473. |Biochem Pharmacol. 2024 Dec;230 (Pt 1) :116574.|BMC Musculoskelet Disord. 2022 May 30;23 (1) :514.|Bone Joint Res. 2023 Nov 1;12 (11) :677-690.|Comput Math Methods Med. 2021 Aug 2:2021:3337514.|Eur J Histochem. 2025 Jan 21;69 (1) .|Eur J Pharmacol. 2021 Jun 5:900:174069.|FASEB J. 2025 Aug 31;39 (16) :e70945.|Infect Genet Evol. 2022 Jan:97:105158.|J Agric Food Chem. 2023 Oct 25;71 (42) :15538-15552.|J Cell Physiol. 2019 Dec;234 (12) :22463-22476.|J Clin Neurosci. 2020 Aug;78:365-370.|J Mol Histol. 2021 Jun;52 (3) :521-537.|J Nanobiotechnology. 2025 Jul 22;23 (1) :535.|J Nutr. 2020 Jul 1;150 (7) :1731-1737.|Mol Carcinog. 2024 Nov;63 (11) :2190-2204.|Biochem Pharmacol. 2025 May:235:116820.|Bioengineered. 2022 May;13 (5) :12847-12862.|Ecotoxicol Environ Saf. 2025 Jun 4:300:118460.|Exp Eye Res. 2023 Feb:227:109365.|Front Biosci (Landmark Ed) . 2025 Apr 25;30 (4) :25221.|Front Pharmacol. 2021 May 31:12:653272.|Genomics. 2025 Jun 1:111067.|Int Immunopharmacol. 2024 Jul 23:139:112720.|J Cardiothorac Surg. 2024 Dec 20;19 (1) :665.|J Clin Invest. 2024 Jun 18:e178303.|J Ethnopharmacol. 2024 Aug 31:118738.|J Food Sci. 2025 Apr;90 (4) :e70217.|J Inflamm Res. 2021 Sep 16;14:4669-4686.|New Phytol. 2024 May 13.|Phytomedicine. 2021 Nov:92:153740.|Respir Res. 2025 Apr 12;26 (1) :136.|Tissue Cell. 2023 Dec:85:102218.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

TCP11L2 Antibody
orb1244364 100 µL

TCP11L2 Antibody

Sign In for Pricing
View Details
KLRA1 (Killer Cell Lectin-Like Receptor Subfamily A, Member 1, KLRA#, LY49L, Ly-49L, Ly49, MGC126520, MGC126522) (MaxLight 650)
MBS6222912-01 0.1 mL

KLRA1 (Killer Cell Lectin-Like Receptor Subfamily A, Member 1, KLRA#, LY49L, Ly-49L, Ly49, MGC126520, MGC126522) (MaxLight 650)

Sign In for Pricing
View Details
KLRA1 (Killer Cell Lectin-Like Receptor Subfamily A, Member 1, KLRA#, LY49L, Ly-49L, Ly49, MGC126520, MGC126522) (MaxLight 650)
MBS6222912-02 5x 0.1 mL

KLRA1 (Killer Cell Lectin-Like Receptor Subfamily A, Member 1, KLRA#, LY49L, Ly-49L, Ly49, MGC126520, MGC126522) (MaxLight 650)

Sign In for Pricing
View Details
MEF3 for Basic Luciferase Vectors (LR-2XXX)
LR-2056 1 Each

MEF3 for Basic Luciferase Vectors (LR-2XXX)

Sign In for Pricing
View Details
Hexokinase, Type IV (HK IV, HKIV, Hexokinase-4, HK4, FGQTL3, Glucokinase, GCK, GK, GLK, Hexokinase-D, HHF3, HXKP, LGLK, MODY2) (MaxLight 405) discontinued
127825-ML405 100 µL

Hexokinase, Type IV (HK IV, HKIV, Hexokinase-4, HK4, FGQTL3, Glucokinase, GCK, GK, GLK, Hexokinase-D, HHF3, HXKP, LGLK, MODY2) (MaxLight 405) discontinued

Sign In for Pricing
View Details
Anti-HEN1 Antibody
MBS8307435-01 0.03 mL

Anti-HEN1 Antibody

Sign In for Pricing
View Details